VeriSIM Life is developing a computational bioplatform that predicts the clinical outcomes of new drugs before clinical trials. Clinical trials are timely and expensive. VeriSIM is using AI and machine learning to help circumvent this. VeriSIM has created BIOiSIM, a bio-simulation platform for virtual drug development that can narrow down the number of drug compounds with anticipated value for disease treatment. BIOiSIM is built on data from thousands of species and can be used before preclinical animal trials begin. In addition, BIOiSIM can simulate various administration routes such as IV, oral and transdermal. VeriSIM is continuously improving the platform for more flexibility and to generate customer-ready tools.

<p>VeriSIM Life is developing a computational bioplatform that predicts the clinical outcomes of new drugs before clinical trials. Clinical trials are timely and expensive. VeriSIM is using AI and machine learning to help circumvent this. VeriSIM has created BIOiSIM, a bio-simulation platform for virtual drug development that can narrow down the number of drug compounds with anticipated value for disease treatment. BIOiSIM is built on data from thousands of species and can be used before preclinical animal trials begin. In addition, BIOiSIM can simulate various administration routes such as IV, oral and transdermal. VeriSIM is continuously improving the platform for more flexibility and to generate customer-ready tools.</p>


VeriSIM Life

Founded: 2017
Location: San Francisco, CA
Employee range: 11 - 50
Funding: $15M A Jan 2022; $5.2M Aug 2019

Short description:

Drug notes:

Long description:

Jobs: